title: Influence of prior determination of baseline minimum alveolar concentration (MAC) of isoflurane on the effect of ketamine on MAC in dogs.
abstract: The objective of this study was to determine if prior measurement of the minimum alveolar concentration (MAC) of isoflurane influences the effect of ketamine on the MAC of isoflurane in dogs. Eight mixed-breed dogs were studied on 2 occasions. Anesthesia was induced and maintained using isoflurane. In group 1 the effect of ketamine on isoflurane MAC was determined after initially finding the baseline isoflurane MAC. In group 2, the effect of ketamine on isoflurane MAC was determined without previous measure of the baseline isoflurane MAC. In both groups, MAC was determined again 30 min after stopping the CRI of ketamine. Plasma ketamine concentrations were measured during MAC determinations. In group 1, baseline MAC (mean ± SD: 1.18 ± 0.14%) was decreased by ketamine (0.88 ± 0.14%; P < 0.05). The MAC after stopping ketamine was similar (1.09 ± 0.16%) to baseline MAC and higher than with ketamine (P < 0.05). In group 2, the MAC with ketamine (0.79 ± 0.11%) was also increased after stopping ketamine (1.10 ± 0.17%; P < 0.05). The MAC values with ketamine were different between groups (P < 0.05). Ketamine plasma concentrations were similar between groups during the events of MAC determination. The MAC of isoflurane during the CRI of ketamine yielded different results when methods of same day (group-1) versus separate days (group-2) are used, despite similar plasma ketamine concentrations with both methods. However, because the magnitude of this difference was less than 10%, either method of determining MAC is deemed acceptable for research purposes.
authors: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario.
authors: Giacomo
authors: G
authors: Gianotti
authors: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario.
authors: Alexander
authors: A
authors: Valverde
authors: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario.
authors: Ron
authors: R
authors: Johnson
authors: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario.
authors: Melissa
authors: M
authors: Sinclair
authors: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario.
authors: Thomas
authors: T
authors: Gibson
authors: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario.
authors: Doris H
authors: DH
authors: Dyson
mesh_terms: D000778:Anesthetics, Dissociative / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D018685:Anesthetics, Inhalation / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D000818:Animals; D018592:Cross-Over Studies; D004285:Dogs; D004347:Drug Interactions; D005260:Female; D007530:Isoflurane / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology*; D007649:Ketamine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology*; D008297:Male; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000378:metabolism
chemical_list: D000778:Anesthetics, Dissociative; D018685:Anesthetics, Inhalation; D007649:Ketamine; D007530:Isoflurane